Sentien Biotechnologies Featured on Front Page of Medical Device Daily™

Sentien Biotechnologies was featured on the front page of Medical Device Daily™ on April 7, 2017.  In the article, Sentien CEO Brian Miller discusses the company’s recent $12M Series A round, as well as the upcoming clinical trial of Sentien’s lead product in acute kidney injury patients.  Read more here (subscription may be required).